Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial

Table 1

Baseline characteristics of the patients.

⁢	CGM pre-CSII	CGM post-CSII	Total
(number)	11	11	22
Sex (female/male) (number)	6/5	5/6	11/11
Age (years) (mean, range)	38.5, 20–59	34.8, 19–45	36.6, 19–59
Body-mass index (Kg/m^2) (mean ± SD)
Diabetes duration (years) (mean ± SD)
Daily insulin doses (units/Kg/day) (mean ± SD)

RT-CGM pre-CSII: real-time continuous glucose monitoring before continuous subcutaneous insulin infusion; RT-CGM post-CSII: real-time continuous glucose monitoring after continuous subcutaneous insulin infusion.